In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1594-1597

  Brueggemann, Angela B ^a   Kugler, Kari C ^a   Doern, Gary V ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; 8 METHOXYQUINOLONE; CIPROFLOXACIN; CLINAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SPARFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; HAEMOPHILUS INFLUENZAE TYPE A; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

EID: 0030814012     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1594     Document Type: Article

References (26)

1. Andriole, V. T. 1993. The future of the quinolones. Drugs 45(Suppl. 3):1-7.
2. Applebaum, P. C. 1991. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1996. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob. Agents Chemother. 40:2431-2433.
4. Chin, N. X., J. W. Gu, K. W. Yu, Y. X. Zhang, and H. C. Neu. 1991. In vitro activity of sparfloxacin. Antimicrob. Agents Chemother. 35:567-571.
5. Cruciani, M., and D. Bassetti. 1994. The fluoroquinolones as treatment for infections caused by Gram-positive bacteria. J. Antimicrob. Chemother. 33: 403-417.
6. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
7. Doern, G. V., A. B. Brueggemann, G. Pierce, T. Hogan, H. P. Holley, Jr., and A. Rauch. 1996. Prevalence of antimicrobial resistance among 723 outpatient isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:2884-2886.
8. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
9. Eliopoulos, G. M., K. Klimm, C. T. Eliopoulos, M. J. Ferraro, and R. C. Moellering, Jr. 1993. In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob. Agents Chemother. 37:366-370.
10. Georgopoulos, A., A. Buxbaum, and W. Graninger. 1996. Activity of BAY 12-8039 against 1154 clinical isolates of Streptococcus pneumoniae, abstr. F5, p. 100. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Gould, I. M., K. J. Forbes, and G. S. Gordon. 1994. Quinolone resistant Haemophilus influenzae. J. Antimicrob. Chemother. 33:187-188.
12. Herrington, J. A., J. A. Federici, B. G. Painter, J. M. Remy, M. L. Barbiero, and B. E. Thurberg. 1996. In vitro activity of Bay 12-8039, a new quinolone, abstr. F4, p. 100. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Hooper, D. C., and J. S. Wolfson. 1991. Fluoruquinolone antimicrobial agents. N. Engl. J. Med. 324:384.
14. Jorgensen, J. H., J. S. Redding, L. A. Maher, and A. W. Howell. 1987. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J. Clin. Microbiol. 25:2105-2113.
15. Kitzis, M. D., F. W. Goldstein, M. Miegi, and J. F. Acar. 1996. In vitro activity of Bay 12-8039 against multiply-resistant Staphylococcus aureus, Streptococcus pneumoniae and Enterococcus faecalis, abstr. F12, p. 102. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Lee, B. L., A. M. Padula, R. C. Kimbrough, S. R. Jones, R. E. Chaisson, J. Mills, and M. A. Sande. 1991. Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N. Engl. J. Med. 325:520-521.
17. Morrissey, I., and J. T. Smith. 1993. Activity of quinolone antibacterials against Streptococcus pneumoniae. Drugs 45(Suppl. 3):196-197.
18. National Committee for Clinical Laboratory Standards. 1996. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Pan, X. S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
20. Perez-Trallero, E., J. M. Garcia-Arenzana, J. A. Jimenez, and A. Peris. 1990. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumoniae treated with ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 9:905-906.
21. Piddock, L. J. V. 1994. New quinolones and gram-positive bacteria. Antimicrob. Agents Chemother. 38:163-169.
22. Piddock, L. J. V., and J. Y. Fang. 1992. Selection of quinolone-resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae. J. Antimicrob. Chemother. 30:109-110.
23. Thomson, K. S., S. S. Backes, and C. C. Sanders. 1996. Susceptibility to BAY 12-8039 of pneumococci and staphylococci with varying levels of ciprofloxacin resistance, abstr. F16, p. 102. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activity of Bay 12-8039, a new quinolone, compared to 3 other quinolones and 5 β-lactams, abstr. F6, p. 101. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
25. Wolfson, J. S., and D. C. Hooper. 1989. Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 2:378-424.
26. Woodcock, J. M., J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise. 1997. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.